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Objectives: In this study, we describe the development of a nonallogeneic animal
model of obliterative bronchiolitis–like lesions. Furthermore, we examined
whether chronic rejection alone can lead to the development of obliterative
bronchiolitis or whether additional nonspecific airway inflammation is re-
quired. Methods: Part I: Rats were intratracheally injected with 0.2 ml of
activated charcoal or sorbitol solution (carrier for charcoal control). Animals
were put to death beginning at 2 weeks up to 20 weeks. Part II: Animals were
divided into three groups: group I, underimmunosuppressed Brown Norway to
Lewis lung allografts; group II, charcoal-treated underimmunosuppressed
allografts; and group III, charcoal-treated rats. Animals were put to death at
3 months after transplantation. Results: Part I: In charcoal-laden bronchioles,
subacute nonspecific airway inflammation was detected at 2 weeks. Slow,
subclinical fibroproliferation ensued during the following weeks. Obliterative
bronchiolitis–like lesions were observed in 80% of charcoal-treated animals at
12 weeks. Part II: Allografts developed extensive vascular lesions consistent
with acute and chronic vascular rejection. Obliterative bronchiolitis–like
lesions were scarcely detected. Charcoal-treated allografts demonstrated evi-
dence of diffuse and severe obliterative bronchiolitis–like lesions. Conclusions:
Transtracheal injection of activated charcoal into native lungs results in slowly
progressive airway injury and inflammation leading to obliterative airway
lesions. Inadequate immunosuppression primarily results in chronic vascular
rejection but not obliterative bronchiolitis. Underimmunosuppressed allo-
grafts subjected to nonspecific airway inflammation develop obliterative air-
way lesions that are more prominent than in native lungs. This suggests that
a cofactor to chronic rejection is likely necessary for the development of lung
transplant obliterative bronchiolitis. (J Thorac Cardiovasc Surg 1998;115:822-7)
Lung transplantation has evolved into an acceptedtherapeutic option for patients with end-stage
pulmonary diseases. However, development of
obliterative bronchiolitis (OB) has emerged as the
most important factor limiting long-term survival
after lung transplantation.1
Clinical and experimental findings suggest that
the cause of lung transplant OB is multifactorial.
Chronic rejection is considered to be the most
important allogeneic stimulus.1 Nonallogeneic stim-
uli such as infections, lymphatic disruption, isch-
emia-reperfusion injury, and the side effects of
immunosuppression may also play a role in the
development of OB.1-5 Clinical investigation of
these nonallogeneic factors is often hampered by
the presentation of multiple complications, limited
quantities of biopsied lung tissue, and small num-
bers of affected individuals for study. For these
reasons and to examine the contribution of each of
the possible contributing factors separately, it be-
comes imperative to develop reliable and reproduc-
ible experimental animal models of OB.
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In this study we describe the development of a
nonallogeneic animal model of OB-like lesions by
instillation of a nonspecific airway irritant into the
lungs of rats. Activated charcoal was used as the
nonallogeneic stimulus. In addition, we examined
whether chronic rejection alone or in combination
with a nonallogeneic airway irritant is essential for
extensive OB development in allografts.
Material and methods
Experimental design. Airway injury after intratracheal
administration of activated charcoal was investigated in
native (part I) and allografted (part II) lungs. In part I, we
first determined the optimal dose of activated charcoal
required to elicit mild progressive airway injury while
limiting the number of deaths among the animals. Four
groups of LEW rats (n 5 5 per group) were anesthetized
with an intraperitoneal injection of sodium pentobarbital
(30 mg/kg), intubated under transluminescence with 16-
gauge intravenous catheters, and injected with a range of
doses of Charcadote TFS-50 (200 mg/ml activated char-
coal per 200 mg/ml sorbitol, Pharmascierice Inc., Mon-
treal) from 0.1 ml up to 0.4 ml consecutively. Animals
experiencing respiratory difficulty were mechanically ven-
tilated (Harvard Rodent Ventilator, Harvard Apparatus
Co., Inc., S. Natick, Mass.). Animals were killed 4 weeks
after charcoal administration. Once the optimal dose was
determined, we then proceeded to characterize in detail
the histopathologic evolution of airway lesions. LEW rats
were divided into two groups: control (n 5 25) and
treatment (n 5 25). Control animals were intratracheally
injected with 0.2 ml of sorbitol solution (200 mg/ml,
carrier for charcoal). Treated animals were anesthetized,
intubated, and intratracheally injected with 0.2 ml of
activated charcoal. Animals were sacrificed (n 5 5) at 2, 4,
12, 16, and 20 weeks after sorbitol/charcoal administra-
tion.
In part II of the study, we analyzed whether chronically
rejecting lung allografts are more susceptible to develop-
ment of obliterative airway lesions after exposure to a
nonspecific airway irritant. LEW rats were divided into
three groups: group I, rats receiving allogeneic BN lung
transplants (n 5 5); group II, rats receiving allogeneic BN
lung transplants followed by intratracheal administration
of 0.2 ml of activated charcoal 1 month after transplanta-
tion; and group III (control), LEW rats intratracheally
injected with 0.2 ml of activated charcoal (n 5 5). All
animals were killed at 3 months.
Young adult, male, specific pathogen-free (SPF) LEW
(RT1) and BN (RT1n) rats weighing 250 to 300 gm were
obtained from Harlan Sprague Dawley, Indianapolis, In-
diana. Animals that survived the procedure were subse-
quently housed in isolation and SPF conditions in the
animal care facilities of the Montreal General Hospital.
Diets consisted of sterile rat chow and water. All animals
were given humane care in compliance with the Animal
Care Committee regulations of The Montreal General
Hospital and McGill University and in compliance with
the “Principles of Laboratory Animal Care” formulated
by the National Society for Medical Research and the
“Guide for the Care and Use of Laboratory Animals”
prepared by the National Academy of Sciences and pub-
lished by the National Institutes of Health (NIH Publica-
tion No 85-23, revised 1985).
Lung transplantation and immunosuppression. Left
lung allografts were orthotopically transplanted in the
thorax according to the improved nonsuture external cuff
technique described by our laboratory.6 Postoperative
immunosuppression consisted of two single doses of cy-
closporine A (25 mg/kg IM) given on days 2 and 3 only.
Histology. Resected left lungs were inflated and fixed in
4% paraformaldehyde for 6 hours, then switched to 15%
phosphate buffered saline sucrose overnight and embed-
ded in paraffin. Multiple-step sections from each paraffin
block were cut and stained with hematoxylin and eosin,
van Gieson’s elastin, and Masson’s trichrome stains. Mul-
tiple-step sections from different lung regions (hilum,
upper, lower, and periphery) of each animal were ob-
tained to ensure thorough analysis because histologic
confirmation of clinical OB lesions is often extremely
difficult to detect. A semiquantitative grading system was
used to assess severity of airway injury:
Grade 1—Bronchial epithelial denuding, mild to moder-
ate inflammation within the airway wall and surround-
ing interstitium.
Grade 2—Bronchiolar epithelial denuding, destruction of
the elastica and muscular wall hyperplasia with exten-
sive inflammation extending into peribronchiolar tissue.
Grade 3—Intraluminal cellular proliferation, young gran-
ulation tissue and fibrosis with partial occlusion of the
airway (less than 50% of lumen diameter).
Grade 4—Intraluminal projection or plugging with young
granulation tissue and fibrosis with obliteration of at
least 50% of airway
Sections were graded blindly by four independent ob-
servers.
Statistical analysis. Grade of airway injury is presented
as means 6 standard deviation. Differences between
groups were assessed by analysis of variance, with Fisher’s
PLSD correction for multiple comparisons, with a com-
mercial statistical software program (Slatview 4.0).
Results
Part I
Determining the optimal dose of activated char-
coal. Four weeks after transtracheal installation of
0.1 ml of activated charcoal, evidence of mild focal
airway epithelial injury and inflammation was noted.
Animals receiving 0.2 ml of charcoal demonstrated
mild to moderate inflammation of the terminal
airways with associated submucosal inflammation.
None of these animals died as a result of treatment
within this dose range. Animals receiving 0.3 ml or
0.4 ml of activated charcoal demonstrated similar
histologic changes as animals receiving 0.2 ml. How-
ever, 4 of the 10 animals in these groups combined
died acutely after installation of charcoal. Therefore
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we chose 0.2 ml of activated charcoal as the optimal
dose for our animal model.
Pathologic evolution of airway injury
ACUTE INFLAMMATORY PHASE (2 TO 4 WEEKS). On
low-to-medium magnification, charcoal particles
were observed to be randomly deposited within the
lumen and submucosa of bronchioles, respiratory
bronchioles, and alveolar ducts. On higher magnifi-
cation, charcoal-laden bronchioles demonstrated ev-
idence of moderate acute nonspecific airway inflam-
mation and injury. Admixture of inflammatory cells,
including lymphocytes and polymorphonuclear cells,
was observed histologically (Fig. 1, A). OB-like
lesions were not observed at this time. No apparent
injury was detected in charcoal-free bronchioles.
Nonspecific airway, vascular, and interstitial edema
was detected (Fig. 1, B) in lungs injected with sor-
bitol solution. Airway obliteration was not detected.
PROLIFERATIVE PHASE (12 TO 20 WEEKS). In char-
coal-laden bronchioles focal epithelial sloughing
and replacement by cuboidal-like cells were de-
tected. In the submucosa the smooth muscle layer
was often disrupted by proliferation of granulation
tissue. Progressive intraluminal infiltration by in-
flammatory cells, fibroblasts, and fibrous tissue en-
sued, resulting in varying degrees of airway obliter-
ation (Fig. 1, C). These obliterative airway lesions
were observed focally in four of five charcoal-
treated animals at 12 weeks and in all charcoal-
treated animals by 16 and 20 weeks. Patchy areas of
atelectasis and alveolar interstitial thickening were
also observed in the parenchyma. Charcoal-free
airways were essentially normal without compro-
mise to the lumen.
At 16 to 20 weeks after sorbitol administration,
animals demonstrated near normal recovery of al-
veolar septum, airways, and vasculature (Fig. 1, D).
OB-like lesions were not observed in any of the
sorbitol-treated animals.
Part II. In this experiment we assessed whether
chronically rejecting rat lung allografts are more
susceptible to airway injury and development of
obliterative airway lesions when exposed to a non-
allogeneic airway irritant (charcoal).
At 3 months after transplantation, chronically
rejecting rat lung allografts (group I) demonstrated
evidence of acute grade III to IV vascular rejection.
Diffuse perivenular and periarterial cuffing by mul-
tiple layers of mononuclear cell infiltrates with
extension into the adjacent alveolar septae was
frequently observed. Pathologic abnormalities con-
sistent with chronic vascular rejection were also
observed as noted by endothelialitis, medial wall
hyperplasia (Fig. 1, E), proliferation of the adventi-
tial layer, and extensive neovascularization. In four
of five allografts the distal respiratory airways dem-
onstrated only mild reactive changes. This consisted
of focal epithelial and peribronchial inflammation
without evidence of OB lesions (Fig. 1, F). Late
airway changes consistent with active OB were
observed scarcely in only one of five allografts.
In charcoal-treated lung allografts (group II),
charcoal particles were observed to be randomly
deposited within the distal airways and admixed
eccentrically with inflammatory cells, fibroblasts,
and young granulation tissue. This resulted in devel-
opment of diffuse obliterative airway lesions (Fig. 1,
G to H). In the submucosa the smooth muscle layer
was frequently disrupted by infiltrating inflamma-
tory cells and fibrous tissue. These OB-like lesions
were observed diffusely in all charcoal-treated allo-
grafts. Mean grade of airway injury (Fig. 2) in this
group of animals (3.7 6 0.36) was statistically sig-
nificantly greater than group I (1.63 6 0.35, p 5
0.001) allografts. Evidence of acute and chronic
vascular rejection was present with similar intensity
and distribution as seen in group I.
In group III animals charcoal-laden bronchioles
demonstrated epithelial sloughing over intraluminal
charcoal particles focally admixed with infiltrating
inflammatory cells and foreign body giant cells,
resulting in focal airway obliteration. Mean grade of
airway injury (2.3 6 0.45) was statistically signifi-
cantly (p 5 0.04) less than charcoal-treated allo-
grafts (group II). The pulmonary arterial and ve-
nous system demonstrated mild inflammation with
no compromise to lumen patency.
Discussion
Despite advances in early postoperative manage-
ment of lung transplant recipients, a lack of basic
understanding of the natural history and cause of
OB still prevails.
In this study we initially sought to develop a
reliable nonallogeneic animal model of OB-like
lesions. On the basis of our histologic observations,
the deposition of charcoal particles in the distal
airways induced a process of ongoing subacute
airway epithelial injury and submucosal inflamma-
tion. Infiltration by various inflammatory cell sub-
sets to the charcoal-laden bronchioles likely stimu-
lated the release of a variety of cytokines that can
contribute to further injury and delay in regenera-
tion. We are currently using immunohistochemical
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Fig. 1. Histologic observations in animal groups. Panel A (hematoxylin and eosin 3200), Intraluminal and
peribronchiolar charcoal particles with diffuse lymphocytic infiltrates and extension into adjacent alveolar
septae during the acute inflammatory phase. Charcoal-free airways demonstrate no reactive changes. Panel
B (hematoxylin and eosin 3250), Diffuse peribronchiolar and interstitial edema with mild to moderate
inflammatory cellular infiltrates at 2 weeks after sorbitol administration. Panel C (Masson’s trichrome
3260), Development of OB-like lesions in respiratory bronchioles (arrows) after charcoal treatment in
native LEW lungs at 12 weeks. Panel D (hematoxylin and eosin 3400), Normal recovery of lung
parenchyma at 20 weeks after sorbitol instillation. Panel E (hematoxylin and eosin 3250), Relatively
unremarkable airway with severe medial wall hyperplasia of the vessels in chronically rejecting lung
allografts (3 months). Panel F (hematoxylin and eosin 3100), Mild peribronchiolar and vascular reactive
changes without evidence of OB in chronically rejecting rat lung allografts (3 months). Panel G (hematoxylin
and eosin 3400), OB-like lesions in charcoal-treated lung allografts (3 months). Note residual reactive
bronchiolar epithelium (arrows). Panel H (hematoxylin and eosin 3450), OB-like lesions with evidence of
peribronchiolar smooth muscle disruption (arrow) in charcoal-treated lung allografts (3 months).
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techniques to evaluate the contribution of several
inflammatory cytokines. Preliminary unpublished
data reveal strong diffuse immunostaining for cyto-
kines IL-1b, IL-8, and TNF-a up to 12 weeks after
charcoal administration. Progressive transition from
an acute inflammatory phase to a fibroproliferative
one was observed at approximately 3 months. The
persistence of charcoal particles in the airway lumen
and submucosa augmented fibroblast infiltration
and fibrosis, which ultimately led to obliteration of
the distal airways. Animals receiving treatment with
sorbitol solution also had early nonspecific inflam-
mation of the lung with mild to moderate acute
cellular infiltration develop. However, animals were
able to demonstrate near normal recovery and res-
olution from the sorbitol-induced lesions. This sug-
gests that the presence of activated charcoal is
essential in stimulating chronic subclinical airway
injury and inflammation around the airway.
The use of activated charcoal as a foreign airway
irritant and marker has several advantages. First, it
has the ability to target and induce ongoing nonspe-
cific airway inflammation with reproducible devel-
opment of obliterative airway lesions. Second, ad-
ministering activated charcoal, as a nonallogeneic
cofactor in experimental studies, is technically sim-
pler and safer to use than infectious agents. Third, it
is possible to quantitate the variety of cells, bio-
chemical products, and cytokines that can collect in
the bronchopulmonary compartment using bron-
choalveolar lavage techniques.7 This feature may
allow investigation into the various mechanisms
involved in the development of OB. Finally, pulmo-
nary physiologic measurements can be performed in
these animal models. To this effect, we have begun
preliminary pulmonary function tests in normal and
charcoal-treated rats. Pulmonary function parame-
ters analyzed include lung compliance, resistance,
total lung capacity, and functional residual capacity.
After lung transplantation, host pulmonary de-
fense and mucociliary clearance mechanisms are
impaired.8 In this setting, heightened and prolonged
exposure to harmful antigenic, infectious, or noxious
agents can occur in the airway compartment.9-12
These particles may directly or indirectly stimulate
secondary airway injury. Alternatively, these nonal-
logeneic stimuli may act as cofactors amplifying the
damaging effects of chronic rejection. For this we
demonstrated that instillation of activated charcoal
into inadequately immunosuppressed rat lung allo-
grafts (group II) aggravates and induces progressive
damage to the distal respiratory airways. We de-
tected moderate to severe airway injury and inflam-
mation with evidence of diffuse OB-like lesions in
charcoal-laden allografted bronchioles. Severity and
frequency of obliterative airway lesions was statisti-
cally significantly more pronounced in charcoal-
treated allografts than in charcoal-treated native
lungs (group III). It can be postulated that intact
host defense and mucociliary clearance mechanisms
in native lungs contributed to enhanced clearance of
foreign and desquamated inflammatory products
away from the distal airways. In contrast, without
the addition of a nonspecific airway irritant, inade-
quately immunosuppressed rat lung allografts
(group I) primarily had severe vascular changes
develop consistent with acute and chronic vascular
rejection. Most airways demonstrated only mild
reactive changes. On the other hand, several inves-
tigators reported reproduction of OB lesions as a
result of chronic rejection alone.13, 14 These dispar-
ities may be explained by differences in the cause of
OB in various animal strains and humans. With a
porcine model of lung allotransplantation, Al-Dos-
sari and investigators13 demonstrated that tapering
and discontinuation of immunosuppression results
in progressive fibrous occlusion of bronchioles con-
sistent with OB-like lesions. Immunohistochemical
staining demonstrated increased expression of ma-
jor histocompatibility complex class II antigen off
the bronchiolar epithelium and increased dendritic
cells and CD41 lymphocytes around affected air-
ways. In a mouse model of heterotopic tracheal
transplantation, Hertz and colleagues14 observed
Fig. 2. Mean (6 SD). Semiquantitative grade of airway
injury. Mean grade of airway injury was significantly
greater in charcoal-treated allografts (group II) compared
with both chronically rejecting lung allografts (group I) or
charcoal-treated native lungs (group III).*p 5 0.001 vs
group I, #p 5 0.04 vs group III.
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fibroproliferation of the airway walls in most allo-
grafts. Taking our findings together with these re-
ports, we suggest that the pathogenesis of posttrans-
plant OB is likely to be caused by nonallogeneic
stimuli, allogeneic stimuli, or both factors.
In conclusion, this study describes a novel animal
model of charcoal-induced airway inflammation,
stimulating development of OB-like lesions in native
and transplanted lungs. The histologic features of
the obliterative airway lesions and course of the
disease process is reproducible and resembles in
many ways what is observed in other experimental
models of OB. This animal model may provide a
method to independently study the mechanisms
involved in the pathogenesis of OB in a nonalloge-
neic setting. Alternatively, this model may also be
used to investigate the mechanisms associated with
the development of OB caused by allogeneic and
nonallogeneic stimuli. Finally, we demonstrated that
subjecting chronically rejecting rat lung allografts to
secondary nonspecific airway inflammation results
in severe airway injury and diffuse development of
obliterative airway lesions. The effects of chronic
rejection alone were not sufficient to induce perma-
nent airway injury because OB lesions were almost
nonexistent. This finding suggests that nonspecific
airway inflammation, induced by secondary nonallo-
geneic stimuli, may be necessary for the development
of diffuse OB lesions after lung transplantation.
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